C3.ai Beats Estimates as CEO Touts AI Software Maker's 'Turnaround'

Dow Jones
14小时前

Shares of artificial intelligence software company C3.ai were down in after-hours trading after the company narrowly beat analyst expectations on earnings for the quarter ending in July.

The company reported revenue of $52.1 million and an adjusted loss of 20 cents a share. Analysts were expecting revenue of $52 million on adjusted losses of 26 cents a share.

"The Company has done exactly what a disciplined, focused turnaround should do," CEO Thomas Siebel said.

Shares fell 3% to $10.19 in after-hours trading.

C3.ai, which is led by former Oracle marketing executive Siebel, has had a rough time lately. Its stock has dropped precipitously from its all-time closing high of $177 back in 2020. It's down 20% in 2026 and its shares haven't closed above $20 a share since last August.

Siebel, who founded the company in 2009, announced last July that he was temporarily stepping down as CEO to treat an autoimmune disease that he said affected his vision. The stock fell more than 20% after Siebel later said his health problems had impacted company sales.

Siebel resumed his role in early May. "While my vision remains impaired, it is improving. The health issues I encountered during 2025 are largely resolved," he said at the time.

The company's revenue problems are taking longer to fix. Total revenue increased by less than 2% over the April quarter's figures. Most of that comes from subscription AI software to big businesses and government, which came in at $49.2 million, up less than 2% from the quarter ending in April. A year ago, total revenue was $70.3 million and subscription revenue was $60.3 million.

Investors were likely disappointed by the firm's outlook. For the current quarter, C3.ai is forecasting revenue of $51 million to $55 million, below estimates of $56.6 million among analysts polled by FactSet. Its full year guidance pegs revenue at between $210 million and $240 million, with a midpoint narrowly exceeding estimates of $224.3 million.

 

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10